IGF1R and lymphoma: In male mice, the only lesions showing any evidence of a difference in incidence were the 36% decrease in all fatal tumors and the 47% decrease in fatal lymphoma in Igf1r+/− mice compared to WT mice (Table S3); however, these differences do not attain significance when corrected for multiple comparisons.